Constitutive activity
Constitutive Activity[edit | edit source]
Constitutive activity refers to the intrinsic activity of a receptor in the absence of a ligand. This phenomenon is observed in various types of receptors, including G protein-coupled receptors (GPCRs), ion channels, and nuclear receptors. Constitutive activity is an important concept in pharmacology and cell biology, as it influences the basal level of signaling in cells and can affect the response to drugs.
Mechanism[edit | edit source]
Constitutive activity occurs when a receptor adopts an active conformation without the binding of an agonist. This can happen due to the receptor's inherent structural properties or due to mutations that stabilize the active form. In the case of GPCRs, constitutive activity can lead to the activation of downstream signaling pathways even in the absence of an external stimulus.
Implications in Pharmacology[edit | edit source]
Understanding constitutive activity is crucial for drug development. Drugs that inhibit constitutive activity are known as inverse agonists. These compounds bind to the receptor and stabilize its inactive form, reducing the basal level of activity. In contrast, agonists increase receptor activity, while antagonists block the effects of agonists without affecting constitutive activity.
Examples[edit | edit source]
Several receptors exhibit constitutive activity, including:
- The beta-2 adrenergic receptor, which can activate adenylyl cyclase in the absence of an agonist.
- The histamine H3 receptor, which shows constitutive activity that can be modulated by inverse agonists.
- Mutant forms of the thyrotropin receptor that cause hyperthyroidism due to increased constitutive activity.
Clinical Relevance[edit | edit source]
Constitutive activity has been implicated in various diseases. For example, mutations that increase the constitutive activity of certain receptors can lead to conditions such as hyperthyroidism, cancer, and congenital night blindness. Understanding these mechanisms can aid in the development of targeted therapies.
Also see[edit | edit source]
Template:Receptor pharmacology
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
Medical Disclaimer: WikiMD is not a substitute for professional medical advice. The information on WikiMD is provided as an information resource only, may be incorrect, outdated or misleading, and is not to be used or relied on for any diagnostic or treatment purposes. Please consult your health care provider before making any healthcare decisions or for guidance about a specific medical condition. WikiMD expressly disclaims responsibility, and shall have no liability, for any damages, loss, injury, or liability whatsoever suffered as a result of your reliance on the information contained in this site. By visiting this site you agree to the foregoing terms and conditions, which may from time to time be changed or supplemented by WikiMD. If you do not agree to the foregoing terms and conditions, you should not enter or use this site. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD